1. Home
  2. BHLB vs CRMD Comparison

BHLB vs CRMD Comparison

Compare BHLB & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHLB
  • CRMD
  • Stock Information
  • Founded
  • BHLB 1846
  • CRMD 2006
  • Country
  • BHLB United States
  • CRMD United States
  • Employees
  • BHLB N/A
  • CRMD N/A
  • Industry
  • BHLB Banks
  • CRMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHLB Finance
  • CRMD Health Care
  • Exchange
  • BHLB Nasdaq
  • CRMD Nasdaq
  • Market Cap
  • BHLB 1.1B
  • CRMD 925.6M
  • IPO Year
  • BHLB 2000
  • CRMD 2010
  • Fundamental
  • Price
  • BHLB N/A
  • CRMD $13.09
  • Analyst Decision
  • BHLB Buy
  • CRMD Strong Buy
  • Analyst Count
  • BHLB 4
  • CRMD 8
  • Target Price
  • BHLB $33.88
  • CRMD $17.57
  • AVG Volume (30 Days)
  • BHLB 537.9K
  • CRMD 4.6M
  • Earning Date
  • BHLB 10-23-2025
  • CRMD 10-29-2025
  • Dividend Yield
  • BHLB 2.75%
  • CRMD N/A
  • EPS Growth
  • BHLB 404.16
  • CRMD N/A
  • EPS
  • BHLB 2.56
  • CRMD 0.79
  • Revenue
  • BHLB $438,910,000.00
  • CRMD $121,484,498.00
  • Revenue This Year
  • BHLB $30.73
  • CRMD $404.81
  • Revenue Next Year
  • BHLB $79.15
  • CRMD $56.11
  • P/E Ratio
  • BHLB $10.22
  • CRMD $16.53
  • Revenue Growth
  • BHLB 35.24
  • CRMD 14970.29
  • 52 Week Low
  • BHLB $22.27
  • CRMD $5.60
  • 52 Week High
  • BHLB $32.36
  • CRMD $17.43
  • Technical
  • Relative Strength Index (RSI)
  • BHLB 7.02
  • CRMD 51.16
  • Support Level
  • BHLB $25.90
  • CRMD $12.73
  • Resistance Level
  • BHLB $27.43
  • CRMD $13.83
  • Average True Range (ATR)
  • BHLB 0.49
  • CRMD 0.78
  • MACD
  • BHLB -3.19
  • CRMD -0.16
  • Stochastic Oscillator
  • BHLB 0.00
  • CRMD 44.67

About BHLB Berkshire Hills Bancorp Inc.

Berkshire Hills Bancorp Inc is a holding company. It provides Commercial Banking, Retail Banking, Consumer Lending, Private Banking and Wealth Management services.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: